Literature DB >> 23632967

Prostaglandin E2 type 1 receptors contribute to neuronal apoptosis after transient forebrain ischemia.

Munehisa Shimamura1, Ping Zhou, Barbara Casolla, Liping Qian, Carmen Capone, Hitomi Kurinami, Costantino Iadecola, Josef Anrather.   

Abstract

Cyclooxygenase-2-derived prostaglandin E2 (PGE2) contributes to excitotoxic and ischemic neuronal cell death by engaging neuronal PGE2 type 1 receptors (EP1R). Our previous studies have shown that EP1R signaling resulted in disturbances of intracellular Ca(2+) homeostasis and suppression of the pro-survival protein kinase AKT. The aim of this study was to investigate whether these pathophysiological mechanism have a role in the neuronal cell death after transient forebrain ischemia. Mice were subjected to ischemia/reperfusion by bilateral common carotid artery occlusion. Hippocampal cornu ammonis area 1 (CA1) neuronal cell death was determined 5 days after reperfusion. Animals treated with the EP1R antagonist SC51089 or EP1R-deficient mice (EP1(-/-)) showed significantly less neuronal injury as compared to vehicle-treated wild-type controls. Benefits of EP1R blockage were still evident 14 days after injury. Better neuronal survival was correlated with reduced neuronal caspase-3 activity and decreased nuclear translocation of the apoptosis-inducing factor . Neuroprotection could be reverted by intracerebroventricular administration of the phosphoinositide 3-kinase inhibitor LY294002 and was not further increased by the calcineurin inhibitor FK506. These data implicate EP1R in postischemic neuronal apoptosis possibly by facilitating AKT inhibition.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23632967      PMCID: PMC3734771          DOI: 10.1038/jcbfm.2013.69

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  44 in total

1.  Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD.

Authors:  H G Wang; N Pathan; I M Ethell; S Krajewski; Y Yamaguchi; F Shibasaki; F McKeon; T Bobo; T F Franke; J C Reed
Journal:  Science       Date:  1999-04-09       Impact factor: 47.728

Review 2.  Delayed neuronal death.

Authors:  T Kirino
Journal:  Neuropathology       Date:  2000-09       Impact factor: 1.906

Review 3.  Caspase pathways, neuronal apoptosis, and CNS injury.

Authors:  B A Eldadah; A I Faden
Journal:  J Neurotrauma       Date:  2000-10       Impact factor: 5.269

4.  Pharmacological analysis of cyclooxygenase-1 in inflammation.

Authors:  C J Smith; Y Zhang; C M Koboldt; J Muhammad; B S Zweifel; A Shaffer; J J Talley; J L Masferrer; K Seibert; P C Isakson
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

5.  Increased susceptibility to ischemic brain injury in cyclooxygenase-1-deficient mice.

Authors:  C Iadecola; K Sugimoto; K Niwa; K Kazama; M E Ross
Journal:  J Cereb Blood Flow Metab       Date:  2001-12       Impact factor: 6.200

6.  The cyclooxygenase-2 inhibitor NS-398 ameliorates ischemic brain injury in wild-type mice but not in mice with deletion of the inducible nitric oxide synthase gene.

Authors:  M Nagayama; K Niwa; T Nagayama; M E Ross; C Iadecola
Journal:  J Cereb Blood Flow Metab       Date:  1999-11       Impact factor: 6.200

Review 7.  Programmed cell death in cerebral ischemia.

Authors:  S H Graham; J Chen
Journal:  J Cereb Blood Flow Metab       Date:  2001-02       Impact factor: 6.200

8.  Amelioration of hippocampal neuronal damage after transient forebrain ischemia in cyclooxygenase-2-deficient mice.

Authors:  Tsutomu Sasaki; Kazuo Kitagawa; Kanato Yamagata; Takako Takemiya; Shigeru Tanaka; Emi Omura-Matsuoka; Shiro Sugiura; Masayasu Matsumoto; Masatsugu Hori
Journal:  J Cereb Blood Flow Metab       Date:  2004-01       Impact factor: 6.200

9.  Assessment of the relative contribution of COX-1 and COX-2 isoforms to ischemia-induced oxidative damage and neurodegeneration following transient global cerebral ischemia.

Authors:  Eduardo Candelario-Jalil; Armando González-Falcón; Michel García-Cabrera; Dalia Alvarez; Said Al-Dalain; Gregorio Martínez; Olga Sonia León; Joe E Springer
Journal:  J Neurochem       Date:  2003-08       Impact factor: 5.372

10.  The mGluR5 antagonist 6-methyl-2-(phenylethynyl)pyridine decreases ethanol consumption via a protein kinase C epsilon-dependent mechanism.

Authors:  M Foster Olive; Andrew J McGeehan; Jennifer R Kinder; Thomas McMahon; Clyde W Hodge; Patricia H Janak; Robert O Messing
Journal:  Mol Pharmacol       Date:  2004-11-17       Impact factor: 4.436

View more
  19 in total

1.  The prostaglandin EP1 receptor potentiates kainate receptor activation via a protein kinase C pathway and exacerbates status epilepticus.

Authors:  Asheebo Rojas; Paoula Gueorguieva; Nadia Lelutiu; Yi Quan; Renee Shaw; Raymond Dingledine
Journal:  Neurobiol Dis       Date:  2014-06-19       Impact factor: 5.996

2.  Animal Models of Posttraumatic Seizures and Epilepsy.

Authors:  Alexander V Glushakov; Olena Y Glushakova; Sylvain Doré; Paul R Carney; Ronald L Hayes
Journal:  Methods Mol Biol       Date:  2016

3.  Prohibitin viral gene transfer protects hippocampal CA1 neurons from ischemia and ameliorates postischemic hippocampal dysfunction.

Authors:  Hitomi Kurinami; Munehisa Shimamura; Tao Ma; Liping Qian; Kenzo Koizumi; Laibaik Park; Eric Klann; Giovanni Manfredi; Costantino Iadecola; Ping Zhou
Journal:  Stroke       Date:  2014-03-11       Impact factor: 7.914

4.  Maternal Oxytocin Administration Before Birth Influences the Effects of Birth Anoxia on the Neonatal Rat Brain.

Authors:  Patricia Boksa; Ying Zhang; Dominique Nouel
Journal:  Neurochem Res       Date:  2015-06-25       Impact factor: 3.996

5.  COX-2/PGE2 Pathway Inhibits the Ferroptosis Induced by Cerebral Ischemia Reperfusion.

Authors:  Yunfei Xu; Ying Liu; Kexin Li; Dun Yuan; Shun Yang; Lin Zhou; Yao Zhao; Shuying Miao; Caihong Lv; Jie Zhao
Journal:  Mol Neurobiol       Date:  2022-01-10       Impact factor: 5.682

Review 6.  Therapeutic implications of the prostaglandin pathway in Alzheimer's disease.

Authors:  Eiron Cudaback; Nikolas L Jorstad; Yue Yang; Thomas J Montine; C Dirk Keene
Journal:  Biochem Pharmacol       Date:  2014-01-13       Impact factor: 5.858

Review 7.  Anti-Inflammatory Small Molecules To Treat Seizures and Epilepsy: From Bench to Bedside.

Authors:  Avijit Dey; Xu Kang; Jiange Qiu; Yifeng Du; Jianxiong Jiang
Journal:  Trends Pharmacol Sci       Date:  2016-04-06       Impact factor: 14.819

8.  International Union of Basic and Clinical Pharmacology. CIX. Differences and Similarities between Human and Rodent Prostaglandin E2 Receptors (EP1-4) and Prostacyclin Receptor (IP): Specific Roles in Pathophysiologic Conditions.

Authors:  Xavier Norel; Yukihiko Sugimoto; Gulsev Ozen; Heba Abdelazeem; Yasmine Amgoud; Amel Bouhadoun; Wesam Bassiouni; Marie Goepp; Salma Mani; Hasanga D Manikpurage; Amira Senbel; Dan Longrois; Akos Heinemann; Chengcan Yao; Lucie H Clapp
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

9.  Intracerebral hemorrhage outcomes following selective blockade or stimulation of the PGE2 EP1 receptor.

Authors:  Jenna L Leclerc; Abdullah S Ahmad; Nilendra Singh; Luke Soshnik-Schierling; Ellis Greene; Alex Dang; Sylvain Doré
Journal:  BMC Neurosci       Date:  2015-08-01       Impact factor: 3.288

10.  Detrimental role of the EP1 prostanoid receptor in blood-brain barrier damage following experimental ischemic stroke.

Authors:  Jan C Frankowski; Kelly M DeMars; Abdullah S Ahmad; Kimberly E Hawkins; Changjun Yang; Jenna L Leclerc; Sylvain Doré; Eduardo Candelario-Jalil
Journal:  Sci Rep       Date:  2015-12-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.